S. Shevchuk

954 total citations · 1 hit paper
37 papers, 581 citations indexed

About

S. Shevchuk is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Shevchuk has authored 37 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 10 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in S. Shevchuk's work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Spondyloarthritis Studies and Treatments (7 papers). S. Shevchuk is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Spondyloarthritis Studies and Treatments (7 papers). S. Shevchuk collaborates with scholars based in Ukraine, South Korea and Russia. S. Shevchuk's co-authors include Dae‐Hyun Yoo, Edgar Ramiterre, Pedro C. Miranda, Ulf Müller‐Ladner, Sang Joon Lee, Paweł Hrycaj, Mauricio Abello-Banfi, Volodymyr Kovalenko, Nenad Prodanović and Won Park and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lupus.

In The Last Decade

S. Shevchuk

27 papers receiving 563 citations

Hit Papers

A randomised, double-blind, parallel-group study to demon... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
    2013 487 citations Dae‐Hyun Yoo, Paweł Hrycaj et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Shevchuk Ukraine 6 475 212 154 143 139 37 581
Mariusz Piotrowski Poland 5 438 0.9× 187 0.9× 146 0.9× 139 1.0× 139 1.0× 15 579
Roman Yatsyshyn Ukraine 9 413 0.9× 200 0.9× 150 1.0× 151 1.1× 89 0.6× 36 544
Edgar Ramiterre United States 5 694 1.5× 291 1.4× 227 1.5× 222 1.6× 165 1.2× 10 790
Volodymyr Kovalenko Ukraine 8 895 1.9× 341 1.6× 302 2.0× 286 2.0× 263 1.9× 12 1.1k
HoUng Kim South Korea 8 893 1.9× 284 1.3× 319 2.1× 326 2.3× 209 1.5× 8 1.0k
P.P.M. van Lümig Netherlands 15 497 1.0× 123 0.6× 109 0.7× 131 0.9× 43 0.3× 18 605
W. Porawska Poland 9 499 1.1× 356 1.7× 209 1.4× 198 1.4× 28 0.2× 15 684
Beatriz Pérez-Zafrilla Spain 13 233 0.5× 243 1.1× 42 0.3× 39 0.3× 119 0.9× 17 538
Joyce Ford United States 10 356 0.7× 170 0.8× 69 0.4× 6 0.0× 203 1.5× 15 699
Lisa Smits Netherlands 10 254 0.5× 17 0.1× 112 0.7× 74 0.5× 185 1.3× 17 425

Countries citing papers authored by S. Shevchuk

Since Specialization
Citations

This map shows the geographic impact of S. Shevchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Shevchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Shevchuk more than expected).

Fields of papers citing papers by S. Shevchuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Shevchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Shevchuk. The network helps show where S. Shevchuk may publish in the future.

Co-authorship network of co-authors of S. Shevchuk

This figure shows the co-authorship network connecting the top 25 collaborators of S. Shevchuk. A scholar is included among the top collaborators of S. Shevchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Shevchuk. S. Shevchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shevchuk, S., et al.. (2025). Disease-suppressive mechanisms in contrasting potato-based strip-cropping systems. European Journal of Plant Pathology. 173(2). 469–489.
2.
Shevchuk, S., et al.. (2024). The state of bone mineral density in men with ankylosing spondylitis and its relationship with the course of the disease. Reumatologia/Rheumatology. 62(1). 43–51. 1 indexed citations
3.
4.
Shevchuk, S., et al.. (2023). Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density. Lupus Science & Medicine. 10(2). e000968–e000968. 5 indexed citations
5.
Shevchuk, S., et al.. (2023). AB1046 LEVEL OF VITAMIN D IN MEN WITH ANKYLOSING SPONDYLITIS, CONNECTION WITH DISEASE ACTIVITY AND SEASONALITY. Annals of the Rheumatic Diseases. 82. 1745–1745. 1 indexed citations
6.
Shevchuk, S., et al.. (2022). Acute decompensation of liver cirrhosis and acute-on-chronic liver failure: diagnostic and prognostic criteria, treatment strategy. Reports of Vinnytsia National Medical University. 26(4). 644–652. 1 indexed citations
7.
Shevchuk, S., et al.. (2021). AB0487 HEPSIDINE LEVEL IN PATIENTS WITH ANKYLOSING SPONDYLITIS, RELATIONSHIP WITH HEMOPOESIS AND FERROKINETICS. Annals of the Rheumatic Diseases. 80. 1270–1271. 1 indexed citations
8.
Shevchuk, S., et al.. (2021). LEVELS OF OSTEOCALCIN AND PROCOLLAGEN I N-TERMINAL PROPEPTIDE (PINP) IN MEN SUFFERING FROM ANKYLOSING SPONDYLITIS.. PubMed. 74(10 pt 1). 2384–2391. 1 indexed citations
9.
10.
Shevchuk, S., et al.. (2020). ANEMIA IN PATIENTS WITH ANKYLOSING SPONDYLITIS, ASSOCIATION WITH THE ACTIVITY OF THE INFLAMMATORY PROCESS AND THE SEVERITY OF THE DISEASE. Wiadomości Lekarskie. 73(4). 715–721. 7 indexed citations
11.
Shevchuk, S., et al.. (2019). Possibilities of using hemostasis markers and parameters of hemostatic potential for predicting thrombotic complications in patients with CKD stage VD. Reports of Vinnytsia National Medical University. 23(4). 677–680.
12.
Shevchuk, S., et al.. (2017). The present area of the Dniprovsky reservoirs. 4–11.
13.
14.
15.
16.
Shevchuk, S., et al.. (2014). [PATIENTS WITH HAVE A LEVEL OF ENDOTHELIN-1 AN ANTIFOSFOLIPID SYNDROME: CONNECTION IS WITH MOTION OF DISEASE, DISFUNCTION OF ENDOTHELIA AND ATHEROSCLEROSIS].. PubMed. 26–33. 1 indexed citations
17.
Yoo, Dae‐Hyun, Pedro C. Miranda, Edgar Ramiterre, et al.. (2014). THU0158 Inhibition of Radiographic Progression and Its Association with Clinical Parameters in RA Patients Treated with CT-P13 and Innovator Infliximab in PLANETRA Study. Annals of the Rheumatic Diseases. 73. 234–235. 6 indexed citations
18.
Yoo, Dae‐Hyun, Paweł Hrycaj, Pedro C. Miranda, et al.. (2013). A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. Annals of the Rheumatic Diseases. 72(10). 1613–1620. 487 indexed citations breakdown →
19.
20.
Shevchuk, S., et al.. (2013). [Dyslipidemia in patients with antiphospholipid syndrome and its association with endothelial dysfunction and atherosclerotic changes in the carotid arteries].. PubMed. 38–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariusz Piotrowski Breakdown of academic impact, for papers by Roman Yatsyshyn Breakdown of academic impact, for papers by Edgar Ramiterre Breakdown of academic impact, for papers by Volodymyr Kovalenko Breakdown of academic impact, for papers by HoUng Kim Breakdown of academic impact, for papers by P.P.M. van Lümig Breakdown of academic impact, for papers by W. Porawska Breakdown of academic impact, for papers by Beatriz Pérez-Zafrilla Breakdown of academic impact, for papers by Joyce Ford Breakdown of academic impact, for papers by Lisa Smits
Rankless by CCL
2026